Page last updated: 2024-08-17

cytidine and Nasopharyngeal Carcinoma

cytidine has been researched along with Nasopharyngeal Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, AT; Cher, GB; Hong, RL; Hong, WK; Huat, TE; Hui, EP; Juergens, R; Marur, S; Tsao, A	1
Abe, T; Fukushima, H; Mizuarai, S; Oie, S; Sakamoto, K; Tsujimoto, H	1
Chan, JY; Ho, WK; Man, OY; To, VS; Tsang, CM; Tsang, RK; Tsao, SW; Wei, WI; Wong, TS	1

Trials

1 trial(s) available for cytidine and Nasopharyngeal Carcinoma

Article	Year
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer. Cancer medicine, 2013, Volume: 2, Issue:3 Topics: Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cytidine; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Rate	2013

Article

Year

Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.

Cancer medicine, 2013, Volume: 2, Issue:3

Topics: Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cytidine; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Rate

2013

Other Studies

2 other study(ies) available for cytidine and Nasopharyngeal Carcinoma

Article	Year
3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction. BMC cancer, 2014, Aug-04, Volume: 14 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Cytidine; DNA-Directed RNA Polymerases; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Vault Ribonucleoprotein Particles; Xenograft Model Antitumor Assays	2014
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:3 Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation	2011

Article

Year

3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.

BMC cancer, 2014, Aug-04, Volume: 14

Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Cytidine; DNA-Directed RNA Polymerases; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Vault Ribonucleoprotein Particles; Xenograft Model Antitumor Assays

2014

MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.

Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:3

Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation

2011